John Steuart,
Managing Director & Co-Founder,
Claremont Creek Ventures
Sorry, There is currently no biography for this presenter.
Panel Discussion: Venture Capitalists’ Best Practices on Commercializing Innovation
Thursday, 29 September 2011 at 17:00
Add to Calendar ▼2011-09-29 17:00:002011-09-29 18:00:00Europe/LondonPanel Discussion: Venture Capitalists’ Best Practices on Commercializing InnovationMolecular Diagnostics World Congress in San Francisco, USASan Francisco, USASELECTBIOenquiries@selectbiosciences.com
Successful venture capital investing in molecular diagnostics requires proper commercialization of innovation. But how does this innovation get brought to market? The panel will explore the challenges of commercialization in a still-difficult business environment. These challenges include the cost-efficient development of technology that is truly disruptive yet cost-competitive. Panelists will discuss how to best determine the size of a market and how to assess a competitive landscape. Startups that surmount these challenges then have to weigh the best route to capitalize on the investment, typically via acquisition or an IPO. While IPOs are typically most desired, VCs will discuss why acquisitions are far more common, as well as the pros and cons of guiding the development of a startup for an eventual sale.
Panelists:
Samuel Colella, Co-founder, Versant Ventures
Risa Stack, Partner, Perkins Caufield & Byers
Alexander de Winter, Partner Mohr Davidow
Add to Calendar ▼2011-09-29 00:00:002011-09-30 00:00:00Europe/LondonMolecular Diagnostics World CongressMolecular Diagnostics World Congress in San Francisco, USASan Francisco, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2011-09-29 17:00:002011-09-29 18:00:00Europe/LondonPanel Discussion: Venture Capitalists’ Best Practices on Commercializing InnovationMolecular Diagnostics World Congress in San Francisco, USASan Francisco, USASELECTBIOenquiries@selectbiosciences.com
